The latest rejection came from AstraZeneca / Oxford, which will reduce EU deliveries by about 90 million by the end of March, and about 100,000 doses for Croatia.
Therefore, the first conversation with the Chinese was held on Friday about the possible intervention import of their vector vaccine CanSinoBIO, which is given in a single dose, and in the following week, Sinopharma and Sinovac, vaccines that work on the basis of inactivated SARS-CoV-2 virus, will be discussed. However, it is not yet certain whether an agreement will be reached, given that the Chinese are looking for a contract at the state level before submitting any 'papers' about their vaccines, ie reports on the second and third phase of testing, Jutarnji list writes.
Namely, no proof of vaccine can be concluded without evidence of safety and efficiancy. In addition, the example of Hungary shows that Chinese vaccines are quite expensive, so that country paid one dose of Sinopharma as much as $ 37.50, Hungarian media reported. According to what the Chinese have reported to the public, the effectiveness of Sinopharm is about 75 percent, and so far it has been approved in about twenty countries, including Serbia and Hungary. The efficiency of Convidecija is 65.28 percent, and Sinovac, according to available information, from 50.38 to 83.5 percent, depending on where the studies were done (Brazil and Turkey).
Namely, the fact that EU countries do not receive the vaccine in the expected quantities has triggered a series of talks with manufacturers with whom the EC did not conclude agreements last year, which should have been sufficient to vaccinate all EU citizens.
In order to increase the number of vaccinated, Croatia has recently entered into negotiations with Russia. However, the answer of the Russians is still awaited, who could allegedly send the required 11 documents about their Sputnik V vaccine these days, without which HALMED cannot decide on emergency imports. Government sources believe that buying Sputnik V is a closer option than the Chinese vaccine.
